Literature DB >> 28706863

Non-functional tricuspid valve disease.

Dale S Adler1.   

Abstract

Only 75% of severe tricuspid regurgitation is classified as functional, or related primarily to pulmonary hypertension, right ventricular dysfunction, or a combination of both. Non-functional tricuspid regurgitation occurs when there is damage to the tricuspid leaflets, chordae, papillary muscles, or annulus, independent of right ventricular dysfunction or pulmonary hypertension. The entities that cause non-functional tricuspid regurgitation include rheumatic and myxomatous disease, acquired and genetic connective tissue disorders, endocarditis, sarcoid, pacing, RV biopsy, blunt trauma, radiation, carcinoid, ergot alkaloids, dopamine agonists, fenfluramine, cardiac tumors, atrial fibrillation, and congenital malformations. Over time, severe tricuspid regurgitation that is initially non-functional, can blend into functional tricuspid regurgitation, related to progressive right ventricular dysfunction. Symptoms and signs, including a falling right ventricular ejection fraction, cardiac cirrhosis, ascites, esophageal varices, and anasarca, may occur insidiously and late, but are associated with substantial morbidity and mortality. Attempted valve repair or replacement at late stages carries a high mortality. Crucial to following patients with severe non-functional tricuspid regurgitation is attention to echo quantification of the tricuspid regurgitation and right ventricular function, patient symptoms, and the physical examination.

Entities:  

Keywords:  Tricuspid valve; isolated tricuspid valve surgery; right heart failure; tricuspid annulus; tricuspid regurgitation

Year:  2017        PMID: 28706863      PMCID: PMC5494423          DOI: 10.21037/acs.2017.04.04

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN: 2225-319X


  48 in total

1.  Predictors of residual tricuspid regurgitation after mitral valve surgery.

Authors:  Katsuhiko Matsuyama; Masahiko Matsumoto; Takaaki Sugita; Junichiro Nishizawa; Yoshiyuki Tokuda; Takehiko Matsuo
Journal:  Ann Thorac Surg       Date:  2003-06       Impact factor: 4.330

2.  Common Cause of Mortality in Trauma but Manageable Nonetheless.

Authors:  Andreas R de Biasi; K Patrick Seastedt; Soumitra R Eachempati; Arash Salemi
Journal:  Circulation       Date:  2015-08-11       Impact factor: 29.690

3.  The Forgotten Valve: Isolated Severe Tricuspid Valve Stenosis.

Authors:  Mohammed Al-Hijji; Jae Yoon Park; Abdallah El Sabbagh; Muhammad Amin; Joseph J Maleszewski; Daniel D Borgeson
Journal:  Circulation       Date:  2015-08-18       Impact factor: 29.690

4.  First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve.

Authors:  Joachim Schofer; Klaudija Bijuklic; Claudia Tiburtius; Lorenz Hansen; Adam Groothuis; Rebecca T Hahn
Journal:  J Am Coll Cardiol       Date:  2015-03-04       Impact factor: 24.094

Review 5.  Surgical pathology of the tricuspid valve: a study of 363 cases spanning 25 years.

Authors:  A J Hauck; D P Freeman; D M Ackermann; G K Danielson; W D Edwards
Journal:  Mayo Clin Proc       Date:  1988-09       Impact factor: 7.616

6.  Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation.

Authors:  Saurabh Kumar; Chirag Barbhaiya; Koichi Nagashima; Eue-Keun Choi; Laurence M Epstein; Roy M John; Melanie Maytin; Christine M Albert; Amy L Miller; Bruce A Koplan; Gregory F Michaud; Usha B Tedrow; William G Stevenson
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-12-19

7.  Clinical outcome of isolated tricuspid regurgitation.

Authors:  Yan Topilsky; Vuyisile T Nkomo; Ori Vatury; Hector I Michelena; Thierry Letourneau; Rakesh M Suri; Sorin Pislaru; Soon Park; Douglas W Mahoney; Simon Biner; Maurice Enriquez-Sarano
Journal:  JACC Cardiovasc Imaging       Date:  2014-11-05

8.  Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.

Authors:  P A Pellikka; A J Tajik; B K Khandheria; J B Seward; J A Callahan; H C Pitot; L K Kvols
Journal:  Circulation       Date:  1993-04       Impact factor: 29.690

9.  Medical and surgical outcome of tricuspid regurgitation caused by flail leaflets.

Authors:  David Messika-Zeitoun; Helen Thomson; Michael Bellamy; Christopher Scott; Christophe Tribouilloy; Joseph Dearani; A Jamil Tajik; Hartzell Schaff; Maurice Enriquez-Sarano
Journal:  J Thorac Cardiovasc Surg       Date:  2004-08       Impact factor: 5.209

10.  Impact of tricuspid regurgitation on long-term survival.

Authors:  Jayant Nath; Elyse Foster; Paul A Heidenreich
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

View more
  4 in total

Review 1.  Tricuspid Valve Percutaneous Therapies.

Authors:  Bhaskar Bhardwaj; Joaquin E Cigarroa; Firas Zahr
Journal:  Curr Cardiol Rep       Date:  2022-06-29       Impact factor: 3.955

2.  A comparative study on the results of beating and arrested heart isolated tricuspid valve surgery: A cross-sectional study.

Authors:  Leila Bigdelu; Ali Azari; Zarrin Mashayekhi; Maliheh Dadgarmoghaddam; Vafa Baradaran Rahimi
Journal:  Health Sci Rep       Date:  2022-06-16

Review 3.  Transcatheter tricuspid valve intervention techniques and procedural steps for the treatment of tricuspid regurgitation: a review of the literature.

Authors:  Ahmad Mahdi; Victor Zibara; Kamal Matli; Christy Costanian; Georges Ghanem
Journal:  Open Heart       Date:  2022-06

4.  Echocardiographic assessment of the tricuspid and pulmonary valves: a practical guideline from the British Society of Echocardiography.

Authors:  Abbas Zaidi; David Oxborough; Daniel X Augustine; Radwa Bedair; Allan Harkness; Bushra Rana; Shaun Robinson; Luigi P Badano
Journal:  Echo Res Pract       Date:  2020-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.